eGFR Slope as Predictor of Mortality in Heart Failure Patients
ESC Heart Failure · 01.04.2025 · 12 (2) · 1217-1226
DOI: 10.1002/ehf2.15128 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 27.11.2024. Verfasst von Sofie Verstreken und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, OLV Hospital, Aalst, Belgium. Hauptthemen laut MEDLINE: Heart Failure, Glomerular Filtration Rate, Renal Insufficiency, Chronic, Stroke Volume. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LynxCare Clinical Informatics.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real-world HF patients, assessing eGFR trajectories and their impact on mortality. Methods and results Retrospective clinical data of HF patients were processed using natural language processing. Chronic kidney disease (CKD) was evaluated, and eGFR trajectories were analysed using linear mixed-effects models. Cox proportional hazard models were used to evaluate the relationship between baseline variables and mortality, while joint modelling combined eGFR trends and mortality. The dataset comprised 1986 patients, with a mean age of 74.8 years (SD ± 11.7) and 58% male. At the time of HF diagnosis, 58% of patients were diagnosed with CKD, and 39% presented with heart failure with preserved ejection fraction (HFpEF). The median follow-up duration was 3.16 years, during which 399 patients (20%) died. Patients with CKD were significantly older and exhibited a higher prevalence of myocardial infarction (P = 0.048), coronary revascularization (P = 0.004), stroke (P < 0.001), atrial fibrillation (P < 0.001) and type 2 diabetes (P < 0.001). Mortality rates at 1 and 2 years were nearly twice as high in CKD patients compared with those without (P < 0.001). Notably, CKD was significantly less prevalent among survivors (55% vs. 71%, P < 0.001). Key predictors of mortality included older age, beta-blocker use, prior stroke, lower serum haemoglobin levels, and elevated potassium and NT-proBNP levels. Each 10 mL/min/1.73 m2 decrease in eGFR was associated with a 1.22 (95% CI: 1.10–1.35, P < 0.001) increase in mortality hazard. Additionally, a 1-year decline of 10 mL/min/1.73 m2 in eGFR resulted in a mortality hazard of 1.97 (95% CI: 1.45–2.69, P < 0.001).
Conclusions
CKD is prevalent in a real-world HF population and is an independent predictor of mortality. The current eGFR value and the eGFR slope from the previous year have the potential to be used for assessing individual mortality risk in the clinical follow-up of HF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Center, OLV Hospital, Aalst, Belgium.
- LynxCare Inc., Leuven, Belgium.
ORCID-Profile: Clara L Oeste
Förderung
- LynxCare Clinical Informatics
Zitieren
APA
Verstreken, S., Beles, M., Oeste, C. L., Moya, A., Masuy, I., Dierckx, R., Heggermont, W., Dauw, J., Hens, D., Bartunek, J., & Vanderheyden, M. (2025). eGFR Slope as Predictor of Mortality in Heart Failure Patients. ESC Heart Failure, 12(2), 1217-1226. https://doi.org/10.1002/ehf2.15128
Vancouver
Verstreken S, Beles M, Oeste CL, Moya A, Masuy I, Dierckx R, et al. eGFR Slope as Predictor of Mortality in Heart Failure Patients. ESC Heart Failure. 2025;12(2):1217-1226. doi:10.1002/ehf2.15128
BibTeX
@article{Verstreken2025,
author = {Verstreken, Sofie and Beles, Monika and Oeste, Clara L and Moya, Ana and Masuy, Imke and Dierckx, Riet and Heggermont, Ward and Dauw, Jeroen and Hens, Dries and Bartunek, Jozef and Vanderheyden, Marc},
title = {eGFR Slope as Predictor of Mortality in Heart Failure Patients},
journal = {ESC Heart Failure},
year = {2025},
volume = {12},
number = {2},
pages = {1217--1226},
doi = {10.1002/ehf2.15128}
}
EUVIMED